中外医疗
中外醫療
중외의료
CHINA FOREIGN MEDICAL TREATMENT
2015年
10期
43-44
,共2页
新生儿%败血症%抗生素%并发症
新生兒%敗血癥%抗生素%併髮癥
신생인%패혈증%항생소%병발증
Newborn%Septicemia%Antibiotics%Complications
目的:对新生儿败血症的临床诊断与治疗进行探究。方法对该院于2013年9月—2014年10月收治的104例血培养阳性患儿作为研究对象,对临床资料进行回顾性分析。结果该组患者在经过治疗之后,治愈78例,自动出院22例,死亡4例。治愈率为75.0%;此外,104例患者在经过治疗之后,并发症发生几率减小,其中包括电解质紊乱11例,硬肿症7例,皮肤炎症5例、肺炎2例,不良反应发生率为2.40%;血培养结果中以病原菌以及葡萄球菌为主,占据51%,且病原菌敏感的抗生素主要包括头孢唑啉、头孢哌酮、环丙沙星。结论临床中根据新生儿病史、体征以及药敏结果选取合适抗生素与治疗方法对新生儿败血症有效。
目的:對新生兒敗血癥的臨床診斷與治療進行探究。方法對該院于2013年9月—2014年10月收治的104例血培養暘性患兒作為研究對象,對臨床資料進行迴顧性分析。結果該組患者在經過治療之後,治愈78例,自動齣院22例,死亡4例。治愈率為75.0%;此外,104例患者在經過治療之後,併髮癥髮生幾率減小,其中包括電解質紊亂11例,硬腫癥7例,皮膚炎癥5例、肺炎2例,不良反應髮生率為2.40%;血培養結果中以病原菌以及葡萄毬菌為主,佔據51%,且病原菌敏感的抗生素主要包括頭孢唑啉、頭孢哌酮、環丙沙星。結論臨床中根據新生兒病史、體徵以及藥敏結果選取閤適抗生素與治療方法對新生兒敗血癥有效。
목적:대신생인패혈증적림상진단여치료진행탐구。방법대해원우2013년9월—2014년10월수치적104례혈배양양성환인작위연구대상,대림상자료진행회고성분석。결과해조환자재경과치료지후,치유78례,자동출원22례,사망4례。치유솔위75.0%;차외,104례환자재경과치료지후,병발증발생궤솔감소,기중포괄전해질문란11례,경종증7례,피부염증5례、폐염2례,불량반응발생솔위2.40%;혈배양결과중이병원균이급포도구균위주,점거51%,차병원균민감적항생소주요포괄두포서람、두포고동、배병사성。결론림상중근거신생인병사、체정이급약민결과선취합괄항생소여치료방법대신생인패혈증유효。
Objective clinical diagnosis and treatment of neonatal septicemia inquiry. Methods 104 cases of children with positive as the object of study of blood to our hospital from 2013 September to 2014 October were cultured, the clinical data were retrospectively analyzed. Results neonatal sepsis in the clinical manifestations are not specific, the probability of complications, the mortality rate is high, clinical blood culture as the main means to diagnose, pathogenic bacteria and Staphylococcus aureus in 51.0%, there were 19 cases of Staphylococcus epidermidis, Staphylococcus aureus in 12 cases, 7 cases of hemolytic staphylococci, 3 cases of Escherichia coli, Klebsiella pneumoniae in 2 cases. At present, the clinical antibiotics as the main treatment, mainly including cefazolin, ciprofloxacin, cefoperazone etc.Conclusion the clinical characteristics of children according to the causative agent and sensitive results, on the use of antibiotics to control, can reduce the complication rate and reduce the mortality rate.